DEA schedule
Is velpatasvir and sofosbuvir a controlled substance?
Federal schedule for velpatasvir and sofosbuvir from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
No. Velpatasvir and sofosbuvir is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and velpatasvir and sofosbuvir is not on the DEA controlled substances list.
Run it in Rivvi
Which 2027 plans near you dropped or restricted velpatasvir and sofosbuvir?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 5 prescription listings from 2 labelers, none with a DEA schedule |
| DEA controlled substances list | velpatasvir and sofosbuvir is not on the list |
Velpatasvir and Sofosbuvir NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 61958-2205 | Epclusa | pellet | 37.5 mg/1; 150 mg/1 | Gilead Sciences, Inc. | None |
| 61958-2204 | Epclusa | pellet | 50 mg/1; 200 mg/1 | Gilead Sciences, Inc. | None |
| 61958-2201 | Epclusa | tablet, film coated | 100 mg/1; 400 mg/1 | Gilead Sciences, Inc. | None |
| 61958-2203 | Epclusa | tablet, film coated | 50 mg/1; 200 mg/1 | Gilead Sciences, Inc. | None |
| 72626-2701 | Sofosbuvir and Velpatasvir | tablet, film coated | 100 mg/1; 400 mg/1 | Asegua Therapeutics LLC | None |
Questions
Is velpatasvir and sofosbuvir a controlled substance?
No. Velpatasvir and sofosbuvir is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and velpatasvir and sofosbuvir is not on the DEA controlled substances list.
Is velpatasvir and sofosbuvir a narcotic?
No. Velpatasvir and sofosbuvir is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic. Its FDA established pharmacologic class is Hepatitis C Virus NS5A Inhibitor and Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Velpatasvir and Sofosbuvir
- What is Velpatasvir and Sofosbuvir used for?FDA label uses
- Generic for EpclusaFDA Orange Book
- Is Epclusa a controlled substance?Federal schedule
- Hepatitis C Virus NS5A Inhibitors listFDA drug class
- Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitors listFDA drug class
- Velpatasvir and Sofosbuvir Medicare Part D coverageBy plan and state
- NDC 61958-2201Velpatasvir and Sofosbuvir NDC record
- NDC 61958-2203Velpatasvir and Sofosbuvir NDC record
- NDC 61958-2204Velpatasvir and Sofosbuvir NDC record